The table below shows BIO-TECHNE Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
$311.42M
$295.88M
$286.56M
$316.18M
$297.03M
$289.46M
Cost of revenue
$103.13M
$104.60M
$98.44M
$101.63M
$103.14M
$106.44M
Gross profit
$208.29M
$191.28M
$188.11M
$214.56M
$193.89M
$183.02M
R&D
-
-
-
-
-
-
TECH annual revenue (10-K history)
BIO-TECHNE Corp reported annual revenue of $1.22B for fiscal year 2025. That is up 5.2% from $1.16B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $499.02M (FY 2016) to $1.22B. Figures come from the company's audited annual reports as filed with the SEC.
